Company intelligence / Profile preview

Biotehnos

Otopeni, Ilfov, Romaniabiotehnos.ro ↗
Ownership
Private
Employees
~150
Development stage
Commercial
01

Overview

Produces ALFLUTOP, an original drug consisting of an injectable solution extracted from small marine fish

Therapeutic areas
Rheumatology
Modalities
Injectable solutionspharmaceutical active ingredients from animal and plant origin
Industry
Biotech
02

Drug pipeline

1 asset

alflutop

3
03

Partnerships

Zentiva (part of SANOFI) for vialing operations of ALFLUTOP

Beyond the preview

Go deeper on Biotehnos.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Biotehnos.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call